Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy.
Falini
Brunangelo
B
Martelli
Maria Paola
MP
D000077548:Anaplastic Lymphoma Kinase; D014408:Biomarkers, Tumor / Q000378:metabolism; D049109:Cell Proliferation; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D017730:Ki-1 Antigen / Q000096:biosynthesis; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D017728:Lymphoma, Large-Cell, Anaplastic / Q000145:classification* / Q000175:diagnosis*; D008495:Medical Oncology / Q000379:methods*; D009154:Mutation; D011379:Prognosis; D011505:Protein-Tyrosine Kinases / Q000096:biosynthesis; D020794:Receptor Protein-Tyrosine Kinases; D014178:Translocation, Genetic; D014944:World Health Organization
D014408:Biomarkers, Tumor; D017730:Ki-1 Antigen; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases